U.S. International Trade Commission to Investigate Dermatological Devices
Estimated reading time: 4–6 minutes
The United States International Trade Commission (USITC) has officially started an investigation. This comes after a complaint was filed on June 22, 2026. The complaint was made by Serendia, LLC from Los Angeles, California. They believe that some dermatological treatment devices entering the U.S. are infringing on their patents.
About the Complaint
The complaint claims that four U.S. patents are being violated. These are Patent No. 9,320,536; Patent No. 9,775,774; Patent No. 10,869,812; and Patent No. 12,220,549. Serendia, LLC states these patents relate to some dermatological treatment devices and components. They also say that an industry for these devices exists in the U.S.
What the USITC is Doing
The USITC is investigating if there is a violation as described in Section 337 of the Tariff Act of 1930. This means they are looking at devices brought into the U.S., sold for importation, or sold after being imported. They want to see if these actions break the rules because of patent infringement.
Main Devices Investigated
The investigation focuses on RF microneedling dermatological treatment devices. These devices include consoles, handpieces, and needle tips. The Commission is reviewing specific claims from the patents mentioned to find out if there’s any infringement.
Who is Involved
Serendia, LLC is the complainant in this case. The respondents allegedly in violation include several entities such as:
- InMode Ltd. in Israel
- Invasix Inc. in California, USA
- BTL Industries, Inc. in Massachusetts, USA
- Various BTL Industries entities in the UK, Bulgaria, the Czech Republic, and Cyprus.
Next Steps
Respondents must reply to the complaint within 20 days of receiving it. If they don’t respond in time, they might lose their right to contest the charges. This could lead to orders stopping them from importing or selling these devices in the U.S.
Legal Proceedings
The Chief Administrative Law Judge will pick which judge will oversee the case. The Office of Unfair Import Investigations will not be a party in the investigation. The collected responses will help the USITC decide if any rules were broken. They can issue orders to stop any unfair trade practices if needed.
This is a high-stakes case for all parties involved. The decision will have significant implications for the companies producing these dermatological devices.
Legal Disclaimer
This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
